Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6960452
APP PUB NO 20010020086A1
SERIAL NO

09798338

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are materials that may be used in the design of improved devices and wound treatment platforms though covalent and/or non-covalent attachment of bioactive proteins. The proteins comprise any variety of cell growth and/or healing promoting proteins, such as growth factor. The incorporation of these whole proteins may be designed to provide controlled release thereof in a biological system through further use of enzyme degradation sites. Heparin-binding protein or fusion proteins synthesized to contain a heparin-binding domain are two mechanisms that may be used in providing these properties to a matrix, such as a fibrinogen matrix. The proteins will be used to provide enhanced healing in various tissues including vasculature, skin, nerve, and liver. The materials disclosed will be used to enhance would?? Healing and other generative processes by engineering the fibrin gel to contain appropriate proteins with specifically designed release and/or degradation characteristics.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITAT ZURICH8006 ZÜRICH
EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICHRAEMISTRASSE 101 / ETH TRANSFER 8092 ZURICH 8092

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hubbell, Jeffrey A Zurich, CH 173 9467
Sakiyama, Shelly E Zurich, CH 3 71
Schense, Jason C Zurich, CH 14 276

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation